Photodiagnosis and Photodynamic Therapy
Volume 3, Issue 4 , Pages 205-213 , December 2006

Photodynamic therapy in Argentina

  • Adriana Casas
    • ,
  • Alcira Batlle

      Affiliations

    • Corresponding Author InformationCorrespondence to: Viamonte 1881 10A, 1056 Buenos Aires, Argentina. Tel.: +54 11 4812 3357; fax: +54 11 4811 7447.

References 

  1. Batlle A, Llambias E, Wider E, Tigier H. Porphyrin biosynthesis in soybean callus system -XV. The effect of growth conditions. Int J Biochem. 1975;6:591–606
  2. Fukuda H, Paredes S, Batlle A. Tumour-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms. Drug Des Deliv. 1989;5:133–139
  3. Fukuda H, Casas A, Chueke F, Paredes S, Batlle A. Photodynamic action of endogenously synthesized porphyrins from aminolevulinic acid, using a new model for assaying the effectiveness of tumoural cell killing. Int J Biochem. 1993;25:1395–1398
  4. Casas A, Fukuda H, Di Venosa G, Batlle A. Photosensitisation and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy. Br J Cancer. 2001;85:279–284
  5. Fukuda H, Paredes S, Batlle A. Tumour-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid. Comp Biochem Physiol B. 1992;102:433–436
  6. Fukuda H, Paredes S, Casas A, Chueke F, Batlle A. Potential of liposome-entrapped aminolevulinic acid in cancer therapy. Effect of prior injection of empty liposomes and different routes of administration. The Cancer J. 1992;5:295–299
  7. Dougherty T. Photodynamic Therapy (PDT) of malignant tumours. Crit Rev Oncol Hematol. 1984;2:83–116
  8. Navone N, Polo C, Frisardi A, Batlle A. Mouse mammary carcinoma PBGase and hydroxymethylbilane synthetase. Comp Biochem Physiol B. 1991;98:67–71
  9. Van Hillesberg R, van der Berg J, Kort W, Terpstra O, Wilson J. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology. 1992;103:647–651
  10. Navone NM, Frisardi AL, Resnik ER, Batlle A, Polo C. Porphyrin biosynthesis in human breast cancer. Preliminary mimetic in vitro studies. Med Sci Res. 1988;16:61–62
  11. Navone NM, Polo C, Frisardi AL, Andrade NE, Batlle A. Heme biosynthesis in human breast adenocarcinoma—mimetic in vitro studies and some heme enzymic activity levels. Int J Biochem. 1990;22:1407–1411
  12. Navone NM, Vazquez ES, Polo C, Batlle A. Rhodanese and ALA-S in mammary tumour and liver from normal and tumour-bearing mice. Comp Biochem Physiol B. 1992;102:83–85
  13. Navone NM, Polo C, Dinger R, Batlle A. Heme regulation in mouse mammary carcinoma I. Effect of allyl isopropyl acetamide and veronal on ALA-S, Cyt P450 and Cytochrome oxidase. Int J Biochem. 1990;22:1005–1008
  14. Navone NM, Polo C, Frisardi AL, Batlle A. Mouse mammary carcinoma ALA-D. Comp Biochem Physiol B. 1990;96:729–731
  15. Navone NM, Afonso S, Polo C, Batlle A. Uroporphyrinogen decarboxylase from mouse mammary carcinoma and liver of normal and tumour-bearing mice. Comp Biochem Physiol B. 1992;102:87–92
  16. Polo C, Vazquez ES, Batlle A. Regulation of heme pathway in regenerating mouse liver. Comp Biochem Physiol B. 1992;101:243–246
  17. Polo C, Vazquez SE, Caballero A, Gerez E, Batlle A. Heme biosynthesis in a model of precarcinogenesis pre-initiation. Comp Biochem Physiol B. 1992;103:251–256
  18. Casas A, Fukuda H, Riley P, Batlle A. Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin. Cancer Lett. 1997;121:105–113
  19. Casas A, Fukuda H, Batlle A. Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide. Cancer Biochem Biophys. 1998;16:183–196
  20. Fukuda H, Batlle A, Riley PA. Kinetics of porphyrin accumulation in cultured epithelial cells exposed to ALA. Int J Biochem. 1993;25:1407–1410
  21. Casas A, Fukuda H, Meiss R, Batlle A. Topical and intratumoural photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma. Cancer Lett. 1999;141:29–38
  22. Casas A, Perotti C, Ortel B, DiVenosa G, Saccoliti M, Batlle A, Hasan T. Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells. Int J Oncol, in press.
  23. Casas A, Fukuda H, Batlle A. Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles. Br J Cancer. 1999;81:13–28
  24. Casas A, Fukuda H, Di Venosa G, Batlle A. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitisation. Br J Dermatol. 2000;143:564–572
  25. Kloek J, Beijersbergen van Henegouwen G. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol. 1996;64:994–1000
  26. Gaullier J, Berg K, Peng Q, et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res. 1997;57:1481–1486
  27. Casas A, Batlle A. Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. Current Med Chem Anti-Cancer Agents. 2002;2:465–475
  28. Casas A, Batlle A. Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid—mediated photodynamic therapy. Curr Med Chem. 2006;13(5):1157–1168
  29. Casas A, Batlle A, Butler A, Robertson D, MacRobert A, Riley P. Comparative effect of ALA derivatives on Protoporphyrin IX production in human and rat skin organ cultures. Br J Cancer. 1999;80:1525–1532
  30. Casas A, Perotti C, Fukuda H, Rogers L, Butler A, Batlle A. ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitisation. Br J Cancer. 2001;85:1794–1800
  31. Perotti C, Casas A, Fukuda H, Sacca P, Batlle A. ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice. Br J Cancer. 2002;87:790–795
  32. DiVenosa G, Batlle A, Fukuda H, MacRobert A, Casas A. Distribution of 5-aminolevulinic acid derivatives in mice tissues. Cancer Chemother Pharmacol, in press.
  33. Perotti C, Fukuda H, Di Venosa G, MacRobert A, Batlle A, Casas A. Porphyrin synthesis from ALA derivatives for Photodynamic therapy. In vitro and in vivo studies. Br J Cancer. 2004;90:1660–1665
  34. DiVenosa G, Fukuda H, Batlle A, MacRobert A, Casas A. Photodynamic therapy: regulation of porphyrin synthesis and hydrolysis from ALA esters. J Photochem Photobiol B Biol. 2006;83:129–136
  35. Bermudez Moretti M, Correa Garcia S, Chianelli M, Ramos E, Batlle A. δ-Aminolevulinic acid uptake is mediated by the γ-aminobutyric acid-specific permease UGA4. Cell Mol Biol. 1996;42:519–523
  36. Bermudez Moretti M, Correa Garcia S, Perotti C, Batlle A, Casas A. Delta-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters. Br J Cancer. 2002;87:471–474
  37. Rodriguez L, Batlle A, di Venosa G, Battah S, MacRobert A, Casas A. Mechanisms of uptake of 5-aminolevulic acid esters in mammalian cells. Br J Pharmacol. 2006;147:825–833
  38. Rodríguez L, Batlle A, DiVenosa G, MacRobert A, Battah S, Daniel H, et al. Study of the mechanisms of uptake of 5-aminolevulinic acid derivatives by PEPT1 and PEPT2 transporters as a tool to improve photodynamic therapy of tumours. Int J Biochem Cell Biol. 2006;38:1530–1539
  39. Casas A, Perotti C, Saccoliti M, Sacca P, Fukuda H, Batlle A. ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures. Br J Cancer. 2002;86:837–842
  40. Ambade A, Savariar E, Thayumanavan S. Dendrimeric micelles for controlled drug release and targeted delivery. Mol Pharm. 2005;2:264–272
  41. Battah S, Chee C, Nakanishi H, Gerscher S, MacRobert A, Edwards C. Synthesis and biological studies of 5-aminolevulinic acid-containing dendrimers for photodynamic therapy. Bioconjugate Chem. 2001;12:980–988
  42. Di Venosa G, Casas A, Battah S, et al. Investigation of a novel dendritic derivative of 5-aminolaevulinic acid for photodynamic therapy. Int J Biochem Cell Biol. 2006;38:82–91
  43. DiVenosa G, Perotti C, Fukuda H, Batlle A, Casas A. Sensitivity of cell lines with different nitric oxide production and resistance to NO cytotoxicity. J Photochem Photobiol B Biol. 2005;80:195–202
  44. DiVenosa G, Casas A, Fukuda H, Perotti C, Batlle A. No cross resistance between ALA-mediated photodynamic therapy and nitric oxide. Nitric Oxide. 2005;13:155–162
  45. Spesia M, Lazzeri D, Pascual L, Rovera M, Durantini E. Photoinactivation of Escherichia coli using porphyrin derivatives with different number of cationic charges. FEMS Immunol Med Microbiol. 2005;44:289–295
  46. Milanesio M, Alvarez M, Rivarola V, Silber J, Durantini E. Porphyrin-fullerene C60 dyads with high ability to form photoinduced charge-separated state as novel sensitisers for photodynamic therapy. Photochem Photobiol. 2005;81:891–897
  47. Dupouy E, Lazzeri D, Durantini E. Photodynamic activity of cationic and non-charged Zn(II)tetrapyridinoporphyrazine derivatives: biological consequences in human erythrocytes and Escherichia Coli. Photochem Photobiol Sci. 2004;3:992–998
  48. Lazzeri D, Rovera M, Pascual L, Durantini E. Photodynamic studies and photoinactivation of Escherichia coli using meso-substituted cationic porphyrin derivatives with asymmetric charge distribution. Photochem Photobiol. 2004;80:286–293
  49. Milanesio M, Alvarez M, Silber J, Rivarola V, Durantini E. Photodynamic activity of monocationic and non-charged methoxyphenylporphyrin derivatives in homogeneous and biological media. Photochem Photobiol Sci. 2003;2:926–933
  50. Alvarez M, Moran F, Yslas E, et al. Pharmacokinetic and tumour-photosensitizing properties of methoxyphenyl porphyrin derivative. Biomed Pharmacother. 2003;57:163–168
  51. Pittau R, Pons P, Boeto N, Aoki A. An inexpensive light source for oncologic photodynamic therapy. IEEE Eng Med Biol Mag. 1998;17:105–106
  52. Pons P, Pittau RF, Boetto NA, Garzon R, Aoki A. Prototype of light source for photodynamic therapy in Centre of Electron Microscopy. Rev Fac Cien Med Univ Nac Cordoba. 2000;57:31–36
  53. Pons P, Pittau R, Boetto N, Garzon R, Aoki A. Terapia Fotodinámica de neoplasias dérmicas: experiencia de dos años. Rev Argent Dermatol. 2001;82:208–215

PII: S1572-1000(06)00094-9

doi: 10.1016/j.pdpdt.2006.06.003

Photodiagnosis and Photodynamic Therapy
Volume 3, Issue 4 , Pages 205-213 , December 2006

Article Tools

* Image Usage & Resolution